Does blood transfusion affect intermediate survival after coronary artery bypass surgery

摘要: Background: The aim of this study was to investigate the impact transfusion blood products on intermediate outcome after coronary artery bypass surgery. Patients: Complete data perioperative in patients undergoing surgery were available from 2001 who operated at our institution. Results: Transfusion any product (relative risk = 1.678, 95% confidence interval 1.087–2.590) an independent predictor all-cause mortality. additive effect each mortality 1.401, 1.203–1.630) and cardiac 1.553, 1.273– 1.895) evident when sum included regression models. However, single model, fresh frozen plasma/Octaplas ® only associated with increased 1.692, 1.222–2.344) 2.125, 1.414–3.194). particularly during first three postoperative months. Since follow-up truncated 3 months, a significant 2.998, 1.053–0.537). Analysis survived or had least months potential showed that not significantly 1.430, 0.880–2.323). Conclusions: is Such seems be limited early period diminishes later on. Among products, use plasma Octaplas main determinant